Profluent

AI-First Protein Design

Berkeley, California, USA

Profluent is an AI-first protein design company that leverages its platform for CRISPR gene editing systems to accelerate the development of genetic medicines.

Shareable draft

Check out Profluent on @MedStartr Today Profluent is an AI-first protein design company that leverages its platform for CRISPR gene editing systems to accelerate the development of genetic medicines. #RettSyndrome #GeneticDisorders #TherapeuticProteinDesign #MentalBehavioralHealth #DrugDiscoveryDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/w6ZTKd75uoA

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

Get Involved in Profluent

1 engagement

How We Help

Problem Statement

Profluent aims to solve challenges in human health and the environment by developing innovative, functional proteins, particularly for genetic disorders like Rett Syndrome, through AI-driven base editing.

Core Technology

AI-driven biological programming

Key Differentiators

AI-first approach to protein design; Integration of large-scale frontier AI models and wet-lab capabilities; World's first open-source, AI-generated gene editor (OpenCRISPR-1); Focus on making biology programmable

Clinical Focus

Development of novel therapeutics through AI-driven protein design, with an initial emphasis on gene editing, particularly CRISPR systems, and expanding into antibodies, antigens, and enzymes for targeted disease treatments like Rett syndrome.

Target Customers

Innovative companies and partners across various therapeutic verticals.

Product Stage

Beta

Company Info

Business Model: B2B
Founded: 2022
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: profluent.com/

Disease Areas

Rett Syndrome Genetic Disorders Therapeutic Protein Design Mental Health

Technologies

AI-first Protein DesignCRISPR Gene EditingGenetic MedicinesBase EditingProtein DesignDeep Generative ModelsLLMsWet LabCRISPR TechnologyGenome EditingAI & Machine Learning

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Profluent?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.